Rajiv Modi, Chairman and managing director of Cadila Pharmaceuticals Ltd said "The VLP technology flu vaccine would be commericialised within next 12 to 18 months" AHMEDABAD: Ahmedabad-based Cadila Pharmaceuticals Ltd, a privately owned drug company by Modi family, will commercialise India’s first virus like particle (VLP) based technology seasonal flu vaccine within next 18 months. The company is also working on antibiotic resistance breaker (ARBs) technology to solve the problem rising from the super-bug – New Delhi Metallo-beta-lactamase-1 (NDM-1).

Rajiv Modi, Chairman and managing director of Cadila Pharmaceuticals Ltd said “The VLP technology ..